CompletedNot Applicable

Evaluation of Heuron CTA for Detecting Suspected Large Vessel Occlusion Using Brain CT Angiography

South Korea270 participantsStarted 2024-02-28

Plain-language summary

This study evaluates Heuron CTA, a software that helps doctors detect blockages in brain blood vessels using CT angiography images. The software's results will be compared with diagnoses made by medical specialists to assess its accuracy. If it performs well, it may help doctors diagnose these conditions more quickly and effectively.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults aged 19 years or older who visited the clinical trial institution for brain CTA images between January 2020 and May 2021, and from November 2021 until IRB approval
✓. Individuals classified into the positive or negative group based on the following criteria:

Exclusion criteria

✕. Cases with poor-quality or incomplete brain CTA images7)
✕. Cases where intracranial prosthetic implants (e.g., catheters, coils) were present
✕. Cases that were previously used for AI model training and internal validation
✕. Any other cases deemed unsuitable for participation in the clinical trial based on the investigator's judgment \* Specific reasons were recorded in the case report form.

What they're measuring

Sensitivity and specificity of Heuron CTA in determining the presence of suspected large vessel occlusion

Timeframe: Within 8 weeks after collecting data

Trial details

NCT IDNCT07546019

SponsorHeuron Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-10-21

View on ClinicalTrials.gov More Large Vessel Occlusion trials